Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Dmochowski

Showing results (151-160 of 184) with videos related to

Pageof 19
Sort By:
Neurourology and Urodynamics|November 14, 2023
Functional neuroimaging related to lower urinary tract sensations: Future directions for study designs and selection of patient groups: ICI-RS 2023Mathijs M de Rijk, Marcus J Drake, Alexander von Gontard, et al.
International Urogynecology Journal|May 27, 2014
Validation of a bladder symptom screening tool in women with incontinence due to overactive bladderLinda Cardozo, David Staskin, Brooke Currie, et al.
Neurourology and Urodynamics|August 1, 2012
The prevalence of lower urinary tract symptoms (LUTS) and overactive bladder (OAB) by racial/ethnic group and age: results from OAB-POLLKarin S Coyne, Chris C Sexton, Jill A Bell, et al.
Journal of the American College of Surgeons|November 27, 2013
Benchmarking the use of a rapid response team by surgical services at a tertiary care hospitalDaniel A Barocas, Chirag S Kulahalli, Jesse M Ehrenfeld, et al.
Journal of Comparative Effectiveness Research|December 5, 2018
Cost-effectiveness of overactive bladder treatments: from the US payer perspectiveBrian Murray, Sam H Hessami, Dmitry Gultyaev, et al.
Neurourology and Urodynamics|November 27, 2015
Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: Final results of a long-term extension studyMichael Kennelly, Roger Dmochowski, Heinrich Schulte-Baukloh, et al.
Neuromodulation : Journal of the International Neuromodulation Society|May 13, 2016
The Impact of Pallidal and Subthalamic Deep Brain Stimulation on Urologic Function in Parkinson's DiseaseStephen Mock, David J Osborn, Elizabeth T Brown, et al.
Neurourology and Urodynamics|December 3, 2025
How Can We Make Progress in the Management of Bladder Pain Syndrome? ICI-RS 2025Sachin Malde, Sanjay Sinha, Roger Dmochowski, et al.
The Journal of Urology|October 17, 2007
Efficacy, safety and tolerability of fesoterodine for overactive bladder syndromeVictor W Nitti, Roger Dmochowski, Peter K Sand, et al.
European Urology|November 5, 2013
Detrusor underactivity and the underactive bladder: a new clinical entity? A review of current terminology, definitions, epidemiology, aetiology, and diagnosisNadir I Osman, Christopher R Chapple, Paul Abrams, et al.
Pageof 19

Showing results (151-160 of 184) with videos related to

Sort By:
Pageof 19
Neurourology and Urodynamics|November 14, 2023
Functional neuroimaging related to lower urinary tract sensations: Future directions for study designs and selection of patient groups: ICI-RS 2023Mathijs M de Rijk, Marcus J Drake, Alexander von Gontard, et al.
International Urogynecology Journal|May 27, 2014
Validation of a bladder symptom screening tool in women with incontinence due to overactive bladderLinda Cardozo, David Staskin, Brooke Currie, et al.
Neurourology and Urodynamics|August 1, 2012
The prevalence of lower urinary tract symptoms (LUTS) and overactive bladder (OAB) by racial/ethnic group and age: results from OAB-POLLKarin S Coyne, Chris C Sexton, Jill A Bell, et al.
Journal of the American College of Surgeons|November 27, 2013
Benchmarking the use of a rapid response team by surgical services at a tertiary care hospitalDaniel A Barocas, Chirag S Kulahalli, Jesse M Ehrenfeld, et al.
Journal of Comparative Effectiveness Research|December 5, 2018
Cost-effectiveness of overactive bladder treatments: from the US payer perspectiveBrian Murray, Sam H Hessami, Dmitry Gultyaev, et al.
Neurourology and Urodynamics|November 27, 2015
Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: Final results of a long-term extension studyMichael Kennelly, Roger Dmochowski, Heinrich Schulte-Baukloh, et al.
Neuromodulation : Journal of the International Neuromodulation Society|May 13, 2016
The Impact of Pallidal and Subthalamic Deep Brain Stimulation on Urologic Function in Parkinson's DiseaseStephen Mock, David J Osborn, Elizabeth T Brown, et al.
Neurourology and Urodynamics|December 3, 2025
How Can We Make Progress in the Management of Bladder Pain Syndrome? ICI-RS 2025Sachin Malde, Sanjay Sinha, Roger Dmochowski, et al.
The Journal of Urology|October 17, 2007
Efficacy, safety and tolerability of fesoterodine for overactive bladder syndromeVictor W Nitti, Roger Dmochowski, Peter K Sand, et al.
European Urology|November 5, 2013
Detrusor underactivity and the underactive bladder: a new clinical entity? A review of current terminology, definitions, epidemiology, aetiology, and diagnosisNadir I Osman, Christopher R Chapple, Paul Abrams, et al.
Pageof 19